Ranjeet Dash
Ranjeet Dash
Senior Scientist, The Janssen Pharmaceutical Companies of Johnson & Johnson
Verified email at its.jnj.com - Homepage
Title
Cited by
Cited by
Year
Role of mucoadhesive polymers in enhancing delivery of nimodipine microemulsion to brain via intranasal route
R Pathak, RP Dash, M Misra, M Nivsarkar
Acta Pharmaceutica Sinica B 4 (2), 151-160, 2014
702014
Antithrombocytopenic activity of carpaine and alkaloidal extract of Carica papaya Linn. leaves in busulfan induced thrombocytopenic Wistar rats
V Zunjar, RP Dash, M Jivrajani, B Trivedi, M Nivsarkar
Journal of ethnopharmacology 181, 20-25, 2016
392016
N-(Pivaloyloxy)alkoxy-carbonyl Prodrugs of the Glutamine Antagonist 6-Diazo-5-oxo-l-norleucine (DON) as a Potential Treatment for HIV Associated …
MT Nedelcovych, L Tenora, BH Kim, J Kelschenbach, W Chao, E Hadas, ...
Journal of medicinal chemistry 60 (16), 7186-7198, 2017
372017
Two decades-long journey from riluzole to edaravone: Revisiting the clinical pharmacokinetics of the only two amyotrophic lateral sclerosis therapeutics
RP Dash, NR Babu, R Jayachandra, Srinivas
Clinical Pharmacokinetics, 2018
322018
Comparative pharmacokinetic profiles of picrosides I and II from kutkin, Picrorhiza kurroa extract and its formulation in rats
D Upadhyay, RP Dash, S Anandjiwala, M Nivsarkar
Fitoterapia 85, 76-83, 2013
322013
Therapeutic potential and utility of elacridar with respect to P-glycoprotein inhibition: An insight from the published in vitro, preclinical and clinical studies
RP Dash, RJ Babu, NR Srinivas
European journal of drug metabolism and pharmacokinetics 42 (6), 915-933, 2017
312017
Design, synthesis and biological evaluation of novel pyrazolo-pyrimidinones as DPP-IV inhibitors in diabetes
SR Sagar, JK Agarwal, DH Pandya, RP Dash, M Nivsarkar, KK Vasu
Bioorganic & medicinal chemistry letters 25 (20), 4428-4433, 2015
222015
Simultaneous quantification of berberine and lysergol by HPLC‐UV: evidence that lysergol enhances the oral bioavailability of berberine in rats
S Patil, RP Dash, S Anandjiwala, M Nivsarkar
Biomedical Chromatography 26 (10), 1170-1175, 2012
222012
N-substituted prodrugs of mebendazole provide improved aqueous solubility and oral bioavailability in mice and dogs
SC Zimmermann, T Tichı, J Vávra, RP Dash, EC Slusher, AJ Gadiano, ...
Journal of Medicinal Chemistry, 2018
202018
Evaluation of GABAergic transmission modulation as a novel functional target for management of multiple sclerosis: exploring inhibitory effect of GABA on glutamate-mediated …
AA Gilani, RP Dash, MN Jivrajani, SK Thakur, M Nivsarkar
Advances in pharmacological sciences 2014, 2014
192014
Increased intestinal P-glycoprotein expression and activity with progression of diabetes and its modulation by epigallocatechin-3-gallate: Evidence from pharmacokinetic studies
RP Dash, B Ellendula, M Agarwal, M Nivsarkar
European journal of pharmacology 767, 67-76, 2015
172015
Reappraisal and perspectives of clinical drug–drug interaction potential of α-glucosidase inhibitors such as acarbose, voglibose and miglitol in the treatment of type 2 …
RP Dash, RJ Babu, NR Srinivas
Xenobiotica 48 (1), 89-108, 2018
162018
Discovery of a para-Acetoxy-benzyl Ester Prodrug of a Hydroxamate-Based Glutamate Carboxypeptidase II Inhibitor as Oral Therapy for Neuropathic Pain
R Rais, J Vávra, T Tichý, RP Dash, AJ Gadiano, L Tenora, L Monincová, ...
Journal of medicinal chemistry 60 (18), 7799-7809, 2017
162017
Review of the pharmacokinetics of dalbavancin, a recently approved lipoglycopeptide antibiotic
RP Dash, RJ Babu, NR Srinivas
Infectious Diseases 49 (7), 483-492, 2017
162017
Implication of novel bis‐imidazopyridines for management of A lzheimer's disease and establishment of its role on protein phosphatase 2 A activity in brain
KD Parekh, RP Dash, AN Pandya, KK Vasu, M Nivsarkar
Journal of Pharmacy and Pharmacology 65 (12), 1785-1795, 2013
152013
Comparative pharmacokinetics profile of Vasa Swaras with vasicine and vasicinone
RP Dash, BF Chauhan, S Anandjiwala, M Nivsarkar
Chromatographia 71 (7), 609-615, 2010
142010
Comparative pharmacokinetics of three SGLT-2 inhibitors sergliflozin, remogliflozin and ertugliflozin: an overview
RP Dash, RJ Babu, NR Srinivas
Xenobiotica 47 (11), 1015-1026, 2017
122017
Formulation and pharmacokinetic evaluation of hard gelatin capsule encapsulating lyophilized Vasa Swaras for improved stability and oral bioavailability of vasicine
T Vyas, RP Dash, S Anandjiwala, M Nivsarkar
Fitoterapia 82 (3), 446-453, 2011
122011
Critical Assessment of Pharmacokinetic Drug–Drug Interaction Potential of Tofacitinib, Baricitinib and Upadacitinib, the Three Approved Janus Kinase Inhibitors for Rheumatoid …
V Veeravalli, RP Dash, JA Thomas, RJ Babu, LMV Madgula, NR Srinivas
Drug safety 43 (8), 711-725, 2020
112020
A novel and potent brain penetrant inhibitor of extracellular vesicle release
C Rojas, M Sala, AG Thomas, A Datta Chaudhuri, SW Yoo, Z Li, RP Dash, ...
British journal of pharmacology 176 (19), 3857-3870, 2019
112019
The system can't perform the operation now. Try again later.
Articles 1–20